Oklahoma 2022 Regular Session

Oklahoma House Bill HB2676 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1		-	An Act
2		-	ENROLLED HOUSE
	1	+
	2	+
	3	+	SENATE FLOOR VERSION - HB2676 SFLR Page 1
	4	+	(Bold face denotes Committee Amendments) 1
	5	+	2
	6	+	3
	7	+	4
	8	+	5
	9	+	6
	10	+	7
	11	+	8
	12	+	9
	13	+	10
	14	+	11
	15	+	12
	16	+	13
	17	+	14
	18	+	15
	19	+	16
	20	+	17
	21	+	18
	22	+	19
	23	+	20
	24	+	21
	25	+	22
	26	+	23
	27	+	24
	28	+
	29	+	SENATE FLOOR VERSION
	30	+	March 29, 2021
	31	+
	32	+
	33	+	ENGROSSED HOUSE
3	34		BILL NO. 2676 By: Marti and Davis of the
4	35		House
5	36
6	37		and
7	38
8	39		Weaver and Bullard of the
9	40		Senate
10		-
11		-
12	41
13	42
14	43
15	44
16	45		An Act relating to public health and safety; amending
17	46		63 O.S. 2011, Section 2 -309, as last amended by
18	47		Section 1, Chapter 255, O.S.L. 2018 (63 O.S. Supp.
19	48		2020, Section 2-309), which relates to the Uniform
20	49		Controlled Dangerous Substances Act; updating name of
21	50		agency; exempting certain practitioners from
22	51		electronic prescription requirements for controlled
23	52		dangerous substances; allowing for the util ization of
24	53		electronic prescriptions under certain circumstances;
25	54		modifying internal statutory references; requiring
26	55		practitioners to register with certain agency in
27	56		order to purchase prescription forms; removing fee
28	57		exemption and time period for valid regi strations;
29	58		directing practitioners to purchase prescription
30	59		forms from list of approved vendors; allowing certain
31	60		content to be included on prescription forms;
32	61		expanding definition to allow for the inclusion of
33	62		certain information on electronic prescriptio ns;
34	63		clarifying authority of licensed practitioners to
35	64		purchase prescription forms; and providing an
36	65		effective date.
37	66
38	67
39	68
40		-
41		-	SUBJECT: Public health and safety
42		-
43	69		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
44		-	ENR. H. B. NO. 2676 Page 2
45	70		SECTION 1. AMENDATORY 63 O.S. 2011, Section 2 -309, as
46	71		last amended by Section 1, Chapter 255, O.S.L. 2018 (63 O.S. Supp.
47	72		2020, Section 2-309), is amended to read as follows:
	73	+
	74	+	SENATE FLOOR VERSION - HB2676 SFLR Page 2
	75	+	(Bold face denotes Committee Amendments) 1
	76	+	2
	77	+	3
	78	+	4
	79	+	5
	80	+	6
	81	+	7
	82	+	8
	83	+	9
	84	+	10
	85	+	11
	86	+	12
	87	+	13
	88	+	14
	89	+	15
	90	+	16
	91	+	17
	92	+	18
	93	+	19
	94	+	20
	95	+	21
	96	+	22
	97	+	23
	98	+	24
48	99
49	100		Section 2-309. A. 1. Except for dosages medically required
50	101		for a period not to excee d forty-eight (48) hours which are
51	102		administered by or on direction of a practitioner, other than a
52	103		pharmacist, or medication dispensed directly by a practitioner,
53	104		other than a pharmacist, to an ultimate user, no controlled
54	105		dangerous substance included in S chedule II, which is a prescription
55	106		drug as determined under regulation promulgated by the State Board
56	107		of Pharmacy, shall be dispensed without an electronic prescription
57	108		of a practitioner; provided, that in emergency situations, as
58	109		prescribed by the State Board of Pharmacy by regulation, such drug
59	110		may be dispensed upon oral prescription reduced promptly to writing
60	111		and filed by the pharmacist in a manner to be prescribed by rules
61	112		and regulations of the Director of the Oklahoma State Bureau of
62	113		Narcotics and Dangerous Drugs Control.
63		-
64	114		2. Electronic prescribing shall be utilized for Schedules II,
65	115		III, IV, and V, subject to the requirements set forth in 21 CFR,
66	116		Section 1311 et seq.
67		-
68	117		3. An electronic prescription with electronic signature may
69	118		serve as an original p rescription, subject to the requirements set
70	119		forth in 21 CFR, Section 1311 et seq.
71		-
72	120		4. Prescriptions shall be retained in conformity with the
73	121		requirements of this section and Section 2 -307 of this title. No
74	122		prescription for a Schedule II substance may be refilled.
75	123
	124	+	SENATE FLOOR VERSION - HB2676 SFLR Page 3
	125	+	(Bold face denotes Committee Amendments) 1
	126	+	2
	127	+	3
	128	+	4
	129	+	5
	130	+	6
	131	+	7
	132	+	8
	133	+	9
	134	+	10
	135	+	11
	136	+	12
	137	+	13
	138	+	14
	139	+	15
	140	+	16
	141	+	17
	142	+	18
	143	+	19
	144	+	20
	145	+	21
	146	+	22
	147	+	23
	148	+	24
	149	+
76	150		5. The electronic prescription requirem ent provided for in this
77	151		section shall not apply to prescriptions for controlled dangerous
78	152		substances issued by any of the following:
79		-
80	153		a. a person licensed to practice veterinary medicine,
81		-
82	154		b. a practitioner who experiences temporary technological
83	155		or electrical failure or other extenuating
84	156		circumstance that prevents the prescription from being
85	157		transmitted electronically; provided, however, that
86	158		the practitioner documents the reason for this
87	159		exception in the medical record of the patient,
88		-	ENR. H. B. NO. 2676 Page 3
89	160		c. a practitioner, other than a pharmacist, who dispenses
90	161		directly to an ultimate user,
91		-
92	162		d. a practitioner who orders a controlled dangerous
93	163		substance to be administered through an on -site
94	164		pharmacy in:
95		-
96	165		(1) a hospital as defined in Section 1-701 of this
97	166		title,
98		-
99	167		(2) a nursing facility as defined in Section 1 -1902
100	168		of this title,
101		-
102	169		(3) a hospice inpatient facility as defined in
103	170		Section 1-860.2 of this title,
104		-
105	171		(4) an outpatient dialysis facility,
106		-
107	172		(5) a continuum of care facility as define d in
108	173		Section 1-890.2 of this title, or
109	174
	175	+	SENATE FLOOR VERSION - HB2676 SFLR Page 4
	176	+	(Bold face denotes Committee Amendments) 1
	177	+	2
	178	+	3
	179	+	4
	180	+	5
	181	+	6
	182	+	7
	183	+	8
	184	+	9
	185	+	10
	186	+	11
	187	+	12
	188	+	13
	189	+	14
	190	+	15
	191	+	16
	192	+	17
	193	+	18
	194	+	19
	195	+	20
	196	+	21
	197	+	22
	198	+	23
	199	+	24
	200	+
110	201		(6) a penal institution listed in Section 509 of
111	202		Title 57 of the Oklahoma Statutes,
112		-
113	203		e. a practitioner who writes a prescription to be
114	204		dispensed by a pharmacy located on federal property,
115	205		provided the practitioner docu ments the reason for
116	206		this exception in the medical record of the patient,
117	207		or
118		-
119	208		f. a practitioner that has received a waiver or extension
120	209		from his or her licensing board ,
121		-
122	210		g. a practitioner who prescribes a controlled dangerous
123	211		substance for a supply that when taken as prescribed
124	212		would be consumed within seve nty-two (72) hours, or
125		-
126	213		h. a practitioner who determines that an electronic
127	214		prescription cannot be issued in a timely manner and
128	215		the condition of the patient is at risk .
129		-
130	216		6. Electronic prescriptions shall not may be utilized under the
131	217		following circumstance s:
132		-	ENR. H. B. NO. 2676 Page 4
133	218		a. compound compounded prescriptions containing two or
134	219		more commercially available products or two or more
135	220		active pharmaceutical ingredients ,
136		-
137	221		b. compounded infusion prescriptions containing two or
138	222		more commercially available products or two or more
139	223		active pharmaceutical ingredients , or
140	224
	225	+	SENATE FLOOR VERSION - HB2676 SFLR Page 5
	226	+	(Bold face denotes Committee Amendments) 1
	227	+	2
	228	+	3
	229	+	4
	230	+	5
	231	+	6
	232	+	7
	233	+	8
	234	+	9
	235	+	10
	236	+	11
	237	+	12
	238	+	13
	239	+	14
	240	+	15
	241	+	16
	242	+	17
	243	+	18
	244	+	19
	245	+	20
	246	+	21
	247	+	22
	248	+	23
	249	+	24
	250	+
141	251		c. prescriptions issued under approved research
142	252		protocols, or
143		-
144	253		d. if the practitioner determines that an electronic
145	254		prescription cannot be issued in a timely manner and
146	255		the condition of the patient is at risk.
147		-
148	256		7. A pharmacist who receives a written, oral or facsimile
149	257		prescription shall not be required to verify that the prescription
150	258		falls under one of the exceptions provided for in paragraph 6 of
151	259		this subsection. Pharmacist s may continue to dispense medications
152	260		from otherwise valid written, oral or facsimile prescriptions that
153	261		are consistent with the provisions of this act.
154		-
155	262		8. Practitioners shall indicate in the health record of a
156	263		patient that an exception to the electronic prescription requirement
157	264		was utilized.
158		-
159	265		9. All prescriptions issued pursuant to paragraphs paragraph 5
160	266		and subparagraph c of paragraph 6 of this subsection shall be issued
161	267		on an official prescription form provided approved by the Oklahoma
162	268		State Bureau of Narcotics and Dangerous Drugs Control.
163		-
164	269		10. a. Effective January 1, 2020, practitioners Practitioners
165	270		shall register be registered with the Oklahoma State
166	271		Bureau of Narcotics and Dangerous Drugs Control in
167	272		order to be issued purchase official prescription
168	273		forms. Such registration shall include, but not be
169	274		limited to, the primary address and the address of
	275	+
	276	+	SENATE FLOOR VERSION - HB2676 SFLR Page 6
	277	+	(Bold face denotes Committee Amendments) 1
	278	+	2
	279	+	3
	280	+	4
	281	+	5
	282	+	6
	283	+	7
	284	+	8
	285	+	9
	286	+	10
	287	+	11
	288	+	12
	289	+	13
	290	+	14
	291	+	15
	292	+	16
	293	+	17
	294	+	18
	295	+	19
	296	+	20
	297	+	21
	298	+	22
	299	+	23
	300	+	24
	301	+
170	302		each place of business to be imprinted on official
171	303		prescription forms. Any change to a registered
172	304		practitioner's registered address shall be promptly
173	305		reported to the practitioner's licensing board and th e
174	306		Bureau by the practitioner in a manner approved by the
175	307		Bureau.
176		-	ENR. H. B. NO. 2676 Page 5
177	308		b. A practitioner's registration shall be without fee and
178	309		subject to approval by the Bureau. Such registration
179	310		shall be valid for a period o f two (2) years and may
180	311		be denied, suspended or re voked by the Bureau upon a
181	312		finding by the Bureau or licensing board that the
182	313		registered practitioner has had any license to
183	314		practice a medical profession revoked or suspended by
184	315		any state or federal agency.
185		-
186	316		c. Where the Bureau has revoked the registration of a
187	317		registered practitioner, the Bureau may revoke or
188	318		cancel any official prescription forms in the
189	319		possession of the registered practitioner. Any
190	320		revocation or any suspension shall require the
191	321		registered practitioner to return all unused official
192	322		prescription forms to the Bureau within fifteen (15)
193	323		calendar days after the date of the written
194	324		notification.
195	325
	326	+	SENATE FLOOR VERSION - HB2676 SFLR Page 7
	327	+	(Bold face denotes Committee Amendments) 1
	328	+	2
	329	+	3
	330	+	4
	331	+	5
	332	+	6
	333	+	7
	334	+	8
	335	+	9
	336	+	10
	337	+	11
	338	+	12
	339	+	13
	340	+	14
	341	+	15
	342	+	16
	343	+	17
	344	+	18
	345	+	19
	346	+	20
	347	+	21
	348	+	22
	349	+	23
	350	+	24
	351	+
196	352		d. c. A practitioner that has had any license to practice
197	353		terminated, revoked or suspended by a state or federal
198	354		agency may, upon restoration of such l icense or
199	355		certificate, register to be issued official
200	356		prescription forms with the Bureau.
201		-
202	357		11. a. Except as provided in subparagraph f of this
203	358		paragraph, the Bureau shall issue official Official
204	359		prescription forms free of charge only to registered
205	360		practitioners in this state. Such forms shall not be
206	361		transferable. The number of official prescription
207	362		forms issued to a registered shall be purchased at the
208	363		expense of the practitioner at any time shall be at
209	364		the discretion of or the employer of the practitioner
210	365		from a list of vendors approved by the Bureau.
211		-
212	366		b. Official prescription forms issued to a registered
213	367		practitioner shall be imprinted only with the primary
214	368		address and may include other addresses listed on the
215	369		registration of the practitioner to identify the place
216	370		of origin. Such prescriptions shall be sent only to
217	371		the primary address of the registered practitioner.
218		-
219	372		c. Official prescription forms issued to of a registered
220		-	practitioner shall be used only by the practitioner to ~~ENR. H. B. NO. 2676 Page 6~~
	373	+	practitioner shall be used only by the practitioner to
221	374		whom they are issued designated on the official
222	375		prescription form.
	376	+
	377	+	SENATE FLOOR VERSION - HB2676 SFLR Page 8
	378	+	(Bold face denotes Committee Amendments) 1
	379	+	2
	380	+	3
	381	+	4
	382	+	5
	383	+	6
	384	+	7
	385	+	8
	386	+	9
	387	+	10
	388	+	11
	389	+	12
	390	+	13
	391	+	14
	392	+	15
	393	+	16
	394	+	17
	395	+	18
	396	+	19
	397	+	20
	398	+	21
	399	+	22
	400	+	23
	401	+	24
223	402
224	403		d. The Bureau may revoke or cancel official prescription
225	404		forms in possession of registered practitioners when
226	405		the license of such practitioner is suspended,
227	406		terminated or revoked.
228		-
229	407		e. Official prescription forms of regis tered
230	408		practitioners who are deceased or who no longer
231	409		prescribe shall be returned to the Bureau at a
232	410		designated address. If the registered practitioner is
233	411		deceased, it is the responsibility of the register ed
234	412		practitioner's estate or lawful designee to ret urn
235	413		such forms.
236		-
237	414		f. The Bureau may issue official prescription forms to
238	415		employees or agents of the Bureau and other government
239	416		agencies for the purpose of preventing, identifying,
240	417		investigating and prosecuti ng unacceptable or illegal
241	418		practices by providers and other persons and assisting
242	419		in the recovery of overpayments under any program
243	420		operated by the state or paid for with state funds.
244	421		Such prescription forms shall be issued for this
245	422		purpose only to indivi duals who are authorized to
246	423		conduct investigations on behalf of the Bureau or
247	424		other government agencies as part of their official
248	425		duties. Individuals and agencies receiving such
249	426		prescription forms for this purpose shall provide
	427	+
	428	+	SENATE FLOOR VERSION - HB2676 SFLR Page 9
	429	+	(Bold face denotes Committee Amendments) 1
	430	+	2
	431	+	3
	432	+	4
	433	+	5
	434	+	6
	435	+	7
	436	+	8
	437	+	9
	438	+	10
	439	+	11
	440	+	12
	441	+	13
	442	+	14
	443	+	15
	444	+	16
	445	+	17
	446	+	18
	447	+	19
	448	+	20
	449	+	21
	450	+	22
	451	+	23
	452	+	24
	453	+
250	454		appropriate assurances to t he Bureau that adequate
251	455		safeguards and security me asures are in place to
252	456		prevent the use of such prescription forms for
253	457		anything other than official government purposes.
254		-
255	458		12. a. Adequate safeguards and security measures shall be
256	459		undertaken by registered pra ctitioners holding
257	460		official prescription forms to assure against the
258	461		loss, destruction, theft or unauthorized use of the
259	462		forms. Registered practitioners shall maintain a
260	463		sufficient but not excessive supply of such forms in
261	464		reserve.
262		-
263	465		b. Registered practitio ners shall immediately notify the
264	466		Bureau, in a manner designated by the Bureau, upon
265		-	their knowledge of the loss, destruction, theft or ~~ENR. H. B. NO. 2676 Page 7~~
	467	+	their knowledge of the loss, destruction, theft or
266	468		unauthorized use of any official prescription forms
267	469		issued to them, as well as the failure to receive
268	470		official prescription forms within a reasonable time
269	471		after ordering them from the vendor approved by the
270	472		Bureau.
271		-
272	473		c. Registered practitioners shall immediately notify the
273	474		Bureau upon their knowledge of any diversion or
274	475		suspected diversion of drugs pursuant to the loss,
275	476		theft or unauthorized use of prescriptions.
	477	+
	478	+	SENATE FLOOR VERSION - HB2676 SFLR Page 10
	479	+	(Bold face denotes Committee Amendments) 1
	480	+	2
	481	+	3
	482	+	4
	483	+	5
	484	+	6
	485	+	7
	486	+	8
	487	+	9
	488	+	10
	489	+	11
	490	+	12
	491	+	13
	492	+	14
	493	+	15
	494	+	16
	495	+	17
	496	+	18
	497	+	19
	498	+	20
	499	+	21
	500	+	22
	501	+	23
	502	+	24
276	503
277	504		B. 1. Except for dosages medically required for a period not
278	505		to exceed seventy-two (72) hours which are administered by or on
279	506		direction of a practitioner, other than a pharmacist, or medication
280	507		dispensed directly by a practitioner, other than a pharmacist, to an
281	508		ultimate user, or the circumstances provided for in paragraphs 5 and
282	509		6 of subsection A of this section, no controlled dangerous substance
283	510		included in Schedule III or IV, which is a prescription drug as
284	511		determined under regulation promulgated by the State Board of
285	512		Pharmacy, shall be dispensed without an electronic prescription.
286		-
287	513		2. Any prescription for a controlled dangerous substance in
288	514		Schedule III, IV or V may not be filled or refilled more than six
289	515		(6) months after the date thereof or be refilled more than five
290	516		times after the date of the prescription, unless renewed by the
291	517		practitioner.
292		-
293	518		C. Whenever it appears to the Director of the Oklahoma State
294	519		Bureau of Narcotics and Dangerous Drugs Control that a drug not
295	520		considered to be a prescription drug under exi sting state law or
296	521		regulation of the State Board of Pharmacy should be so considered
297	522		because of its abuse potential, the Director shall so advise the
298	523		State Board of Pharmacy and furnish to the Board all ava ilable data
299	524		relevant thereto.
300		-
301	525		D. 1. "Prescription", as used in this section, means a
302	526		written, oral or electronic order by a practitioner to a pharmacist
303	527		for a controlled dangerous substance for a particular patient, which
	528	+
	529	+	SENATE FLOOR VERSION - HB2676 SFLR Page 11
	530	+	(Bold face denotes Committee Amendments) 1
	531	+	2
	532	+	3
	533	+	4
	534	+	5
	535	+	6
	536	+	7
	537	+	8
	538	+	9
	539	+	10
	540	+	11
	541	+	12
	542	+	13
	543	+	14
	544	+	15
	545	+	16
	546	+	17
	547	+	18
	548	+	19
	549	+	20
	550	+	21
	551	+	22
	552	+	23
	553	+	24
	554	+
304	555		specifies the date of its issue, and the full name and address of
305	556		the patient and, if the controlled dangerous substance is prescribed
306	557		for an animal, the species of the animal, the name and quantity of
307	558		the controlled dangerous substance prescribed, the directions for
308	559		use, the name and ad dress of the owner of the animal and, if
309		-	written, the signature of the practitioner. When electronically ~~ENR. H. B. NO. 2676 Page 8~~
	560	+	written, the signature of the practitioner. When electronically
310	561		prescribed, the full name of the patient may include the name and
311	562		species of the animal.
312		-
313	563		2. "Registered practitioner ", as used in this section, means a
314	564		licensed practitioner duly registered with the Oklahoma State Bureau
315	565		of Narcotics and Dangerous Drugs Control authorized to be issued
316	566		purchase official prescription forms.
317		-
318	567		E. No person shall solicit, dispense, receive or deliver any
319	568		controlled dangerous substance through the mail, unless the ultimate
320	569		user is personally known to the practitioner and circumstances
321	570		clearly indicate such method of delivery is in the best interest of
322	571		the health and welfare of the ultimate user.
323		-
324	572		SECTION 2. This act shall become effective November 1, 2021.
325		-	ENR. H. B. NO. 2676 Page 9
326		-	Passed the House of Representatives the 8th day of March, 2021.
327		-
328		-
329		-
330		-
331		-	Presiding Officer of the House
332		-	of Representatives
333		-
334		-
335		-	Passed the Senate the 21st day of April, 2021.
336		-
337		-
338		-
339		-
340		-	Presiding Officer of the Senate
341		-
342		-
343		-
344		-	OFFICE OF THE GOVERNOR
345		-	Received by the Office of the Governor this ____________________
346		-	day of ___________________, 20_______, at _______ o'clock _______ M.
347		-	By: _________________________________
348		-	Approved by the Governor of the State of Oklahoma this _________
349		-	day of ___________________, 20_______, at _______ o'clock _______ M.
350		-
351		-
352		-	_________________________________
353		-	Governor of the State of Oklahoma
354		-
355		-	OFFICE OF THE SECRETARY OF STATE
356		-	Received by the Office of the Secretary of State this __________
357		-	day of ___________________, 20_______, at _______ o'clock _______ M.
358		-	By: _________________________________
359		-
	573	+	COMMITTEE REPORT BY: COMMITTEE ON HEALTH AND HUMAN SERVICES
	574	+	March 29, 2021 - DO PASS